Estimation of the progenitor cell yield in a leukapheresis product by previous measurement of CD34+ cells in the peripheral blood

Vox Sanguinis

Volumn 71, Issue 2, 1996, Pages 90-96

  Möhle, Robert ^a,b   Murea, Simona ^a   Pförsich, Margit ^a   Witt, Barbara ^a   Haas, Rainer ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; HEMOPOIETIC GROWTH FACTOR;

ARTICLE; CANCER PATIENT; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKOCYTE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL;

EID: 0029802062     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1996.7120090.x     Document Type: Article

References (23)

1. Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni AM: Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991;77:400-409.
2. Haas R, Möhle R, Frühauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M, Hunstein W: Patient characteristics associated with successfull mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994;83:3787-3794.
3. Bender JG, To LB, Williams S, Schwartzberg LS: Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992;1:329-341.
4. Tricot G, Jagannath S, Vesole D, Nelson J, Tindie S, Miller L, Cheson B, Crowley J, Barlogie B: Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood 1995;85:588-596.
5. van der Wall E, Richel DJ, Holtkamp MJ, Slaper-Cortenbach IC, van der School CE, Dalesio O, Nooijen WJ, Schornagel JH, Rodenhuis S: Bone marrow reconstitution afer high-dose chemotherapy and autologous peripheral progenitor cell transplantation: Effect of graft size. Ann Oncol 1994;5:795-802.
6. Ravagnani F, Siena S, Bregni M, Brando B, Belli N, Lansdorp PM, Notti P, Pellegris G, Gianni AM: Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients. Haematologica 1991;76S1:46-49.
7. Dührsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D: Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988;72:2074-2081.
8. Haas R, Hohaus S, Ehrhardt R, Goldschmidt H, Hunstein W: Autologous blood progenitor cell transplantation in relapsed Hodgkin's disease - The role of hematopoietic growth factors. Bone Marrow Transplant 1993;11S2:30-35.
9. Dreger P, Marquardt P, Haferlach T, Jacobs S, Mulverstedt T, Eckstein V, Suttorp M, Loffler H, Muller-Ruchholtz W, Schmitz N: Effective mobilisation of peripheral blood progenitor cells with Dexa-BEAM and G-CSF: Timing of harvesting and composition of the leukapheresis product. Br J Cancer 1993;68:950-957.
10. Serke S, Sauberlich S, Huhn D: Multiparameter flow-cytometrical quantitation of circulating CD34(+) cells: Correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony assay. Br J Haematol 1991;77: 453-459.
11. Brugger W, Henschler R, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 1994;84:1421-1426.
12. Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen LW, Hardwick A, Moubayed M, Oldham F, Corringham RET, Ho AD: Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: Potential role in allogeneic marrow transplantation. Blood 1995;85: 275-282.
13. Jones HM, Jones SA, Watts MJ, Khwaja A, Mills W, Fielding A, Goldstone AH, Linch DC: Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J Clin Oncol 1994;12:1693-1702.
14. Bender JG, Lum L, Unverzagt KL, Lee W, VanEpps D, George S, Coon J, Ghalie R, McLeod B, Kaizer H, Williams SF: Correlation of colony-forming cells, log-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens. Bone Marrow Transplant 1994;13:479-485.
15. Fritsch G, Emminger W, Buchinger P, Printz D, Gadner H: CD34-positive cell proportions in peripheral blood correlate with colony-forming capacity. Exp Hematol 1991;19:1079-1083.
16. Teixeira G, Lenormand B, Jean P, Fardoun D, Sumereau-Dassin E, Bastit D, Tilly H, Piguet H, Monconduit M, Vannier JP: Immunological evaluation of harvested stem cells obtained by leukapheresis after chemotherapy. Am J Hematol 1992;39:172-175.
17. Brugger W, Bross K, Frisch J, Dern P, Weber B, Mertelsmann R, Kanz L: Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide and cisplatin. Blood 1992;79:1193-1200.
18. Bensinger WI, Longing K, Appelbaum F, Rowley S, Weaver C, Lilleby K, Gooley T, Lynch M, Higano T, Klarnet J, Chauncey T, Storb R, Buckner CD: Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br J Hematol 1994;87:825-831.
19. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallagan J, Berenson RJ: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994;12:28-36.
20. Fruehauf S, Haas R, Zeller WJ, Hunstein W: CD34 selection for purging in multiple myeloma and analysis of CD34+ B cell precursors. Stem Cells 1994;12:95-102.
21. Lasky LC, Ascensao J, McCullough J, Zanjani ED: Steroid modulation of naturally occurring diurnal variation in circulating pluripotential haematopoietic cells (CFU-GEMM). Br J Hematol 1983;55:615-622.
22. Heal JM, Brightman A: Exercise and circulating hematopoietic progenitor cells (CFU-GM) in humans. Transfusion 1987;27:155-158.
23. Berardi A, Geraci L, Quaglietta AM, DiBartolomeo G, Dragani A: Pharmacological mobilization of haemopoietic progenitor cells in human peripheral blood. Haematologica 1990; 75S1:15-17.